ClinicalTrials.gov
ClinicalTrials.gov Menu

Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00266643
Recruitment Status : Completed
First Posted : December 19, 2005
Last Update Posted : August 3, 2007
Sponsor:
Information provided by:
Eli Lilly and Company

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : April 2007